/
Reconciling Aging With HIV Introduction How Is the Epidemiology of HIV Changing in the Reconciling Aging With HIV Introduction How Is the Epidemiology of HIV Changing in the

Reconciling Aging With HIV Introduction How Is the Epidemiology of HIV Changing in the - PowerPoint Presentation

mitsue-stanley
mitsue-stanley . @mitsue-stanley
Follow
346 views
Uploaded On 2019-11-04

Reconciling Aging With HIV Introduction How Is the Epidemiology of HIV Changing in the - PPT Presentation

Reconciling Aging With HIV Introduction How Is the Epidemiology of HIV Changing in the Context of Aging People Living With Diagnosed HIV 2015 Noncommunicable Comorbidities in PLWHIV 45 Years Old ID: 762893

plwhiv hiv screening aging hiv plwhiv aging screening nadcs malignancy nadms burden shift epidemiology related drug factors risk years

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Reconciling Aging With HIV Introduction ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Reconciling Aging With HIV

Introduction

How Is the Epidemiology of HIV Changing in the Context of Aging?

People Living With Diagnosed HIV, 2015

Noncommunicable Comorbidities in PLWHIV ≥ 45 Years Old

POPPY Study: Effects of Aging on Clinical Outcomes of PLWHIV

Accelerated vs Accentuated Aging

Cardiovascular Risk Factors for PLWHIV

Shift in the Epidemiology of HIV-Associated Malignancy

Incidence of NADCs in PLWHIV > 65 Years Old

A Higher Rate of NADCs in Persons With AIDS

NADC-Related Mortality Is Increasing

Why a Shift Toward NADCs?

Global Burden of Disease: Trends in Age-Standardized Mean BMI

Higher Comorbidity Burden Results in Frailty

HIV and Malignancy: Drug-Drug Interaction (DDI) Considerations

Reducing the Burden of Polypharmacy

Risk Factors for Malignancy

Screening for NADMs: HCC

Screening for NADMs: Lung Cancer

Screening for NADMs: Anal Cancer

Liver-Related Diseases as a Primary Cause of Death in PLWHIV

Persistent Increase in HCC Despite HIV Control

Concluding Remarks

Abbreviations

Abbreviations (cont)